Medical devices, healthcare technology and the business of care
510(k) clearance · K254072

BoneVue

Curvebeam AI / Curvebeam, LLC · Decision date Sep 11, 2026

MEDTECHLEDGER EXPLANATIONK254072

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for BoneVue, submitted by Curvebeam AI / Curvebeam, LLC of Hatfield, Pennsylvania, on 11 September 2026 under 510(k) number K254072. The application was received on 18 December 2025. The device falls under 21 CFR 892.1170, classification name Densitometer, Bone, product code KGI, in the Radiology specialty and review panel. A SESE decision is a 510(k) clearance, not a premarket approval.

The available record describes BoneVue as post-processing software whose report addresses bone mineral density of the proximal femur and is used by physicians as an aid in determining fracture risk. The reviewed summary is a traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan. The record does not identify the predicate device, the specific software changes or components assessed, or the performance data supporting equivalence; those details remain in the underlying FDA documents.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Sep 11, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K254072
Regulatory pathway
510(k) premarket notification
Product code
KGI
Decision code
SESE
Decision date
Sep 11, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Densitometer, Bone.

Product code
KGI
FDA device class
2

FDA decision timeline

  1. K254072 received

    Application receipt date recorded by FDA.

  2. K254072 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Curvebeam AI / Curvebeam, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Hatfield, PA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records